SCHEMBL16309554

SCHEMBL16309554

CC1CNCc2cc(OCc3ccccc3)nn21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 7/20 0.43
PKM P14618 1/20 0.40
SLC6A4 P31645 8/20 0.39
HRH4 Q9H3N8 1/20 0.39
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRB2 P47870 1/20 0.38
GABRA4 P48169 1/20 0.38
GABRE P78334 1/20 0.38
GABRA6 Q16445 1/20 0.38
GABRG1 Q8N1C3 1/20 0.38
GABRG3 Q99928 1/20 0.38
GABRQ Q9UN88 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9926436 0.77 GRM5 (0.50)
SCHEMBL18350248 0.77 PKM (0.43) HTR2CPKMSLC6A4
SCHEMBL16270094 0.77 PKM (0.43) HTR2CPKMSLC6A4
SCHEMBL16309413 0.74 PKM (0.40) HTR2CPKMSLC6A4HRH4HTR2A
SCHEMBL16309606 0.74 PKM (0.40) HTR2CPKMSLC6A4HRH4HTR2A
SCHEMBL16309565 0.74 PDCD1 (0.45) HTR2CPKMSLC6A4HRH4HTR2A
SCHEMBL16309555 0.72 GRM5 (0.42) HTR2CPKMSLC6A4HTR2AHTR2B
SCHEMBL24265561 0.71 MAP4K3 (0.46) PKMSLC6A4
SCHEMBL16270138 0.70 PKM (0.44) HTR2CPKMSLC6A4HTR2A
Hydrochloric Acid SCHEMBL26108169 0.70 MAP4K3 (0.45) PKMSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150216863-A1 SUBSTITUTED BICYCLIC ALKOXY PYRAZOLE ANALOGS AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS UNIV VANDERBILT (US) 2015-08-06 US disclosed
US-20150216863-A1 SUBSTITUTED BICYCLIC ALKOXY PYRAZOLE ANALOGS AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS UNIV VANDERBILT (US) 2015-08-06 US disclosed
US-9029366-B2 Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors VANDERBILT UNIVERSITY (US) 2015-05-12 US disclosed
US-9029366-B2 Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors VANDERBILT UNIVERSITY (US) 2015-05-12 US disclosed
WO-2013192346-A9 SUBSTITUTED BICYCLIC ALKOXY PYRAZOLE ANALOGS AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS VANDERBILT UNIVERSITY (US) 2014-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150216863-A1 SUBSTITUTED BICYCLIC ALKOXY PYRAZOLE ANALOGS AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS GRM5, GRIK5, GRM3 HTR2C 67/4885PKM 1138/4885SLC6A4 225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.